Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice ...
Add Yahoo as a preferred source to see more of our stories on Google. If you rely on the lifesaving drug epinephrine for severe allergic reactions, the controversy over high-priced auto-injectors ...
Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...
Kaleo says it will reintroduce its an epinephrine autoinjector in the first half of 2017 The company says it has corrected manufacturing issues that led to a recall last year Pharmaceutical company ...
Please provide your email address to receive an email when new articles are posted on . The costs of epinephrine autoinjectors have decreased since generic options arrived in 2016, but these costs ...
In May, the Food and Drug Administration posted a drug shortage alert, adding Mylan's EpiPen (epinephrine injection) to the drug shortage list. A number of epinephrine auto-injector manufacturers have ...
Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results